Skip to main content
Log in

Amperometric low potential aptasensor for the fucosylated Golgi protein 73, a marker for hepatocellular carcinoma

  • Original Paper
  • Published:
Microchimica Acta Aims and scope Submit manuscript

Abstract

The fucosylated Golgi protein 73 (fuc-GP73) has been used as a criterion to distinguish hepatocellular carcinoma (HCC) from other chronic liver diseases. We describe an amperometric aptasensor for ultrasensitive detection of fuc-GP73 that uses a thiolated aptamer against GP73 as the capture probe, and gold nanoparticles (AuNPs) modified with Avidinlens culinaris agglutinin (A-LCA) as the detection probe. The AuNPs on the surface of a gold electrode provide a large surface for immobilization of A-LCA, so that they can be heavily loaded with biotinylated horse radish peroxidase (B-HRP) via avidin-biotin interactions. This results in enhanced analytical sensitivity. Under optimized conditions and a typical working potential as low as 48 mV (vs. SCE), the dynamic response of the electrode covers the 10 pg·mL−1 to 25 ng·mL−1 fuc-GP73 concentation range, with a 7 pg·mL−1 detection limit (for an S/N ratio of 3). The assay is precise, selective and reproducible. It was applied to the determination of fuc-GP73 in serum.

Schematic of an electrochemical aptasensor for the determination of fucosylated golgi protein 73 (fuc-gp73) based on the avidin-Lens culinaris agglutinin (A-LCA) and biotinylated horse radish peroxidase (B-HRP). It was applied to serum analysis with good sensitivity, selectivity and reproducibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mao Y (2010) Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut 59(12):1687–1693

    Article  CAS  Google Scholar 

  2. Block TM, Comunale MA, Lowman M, Steel LF, Romano PR, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 102(3):779–784

    Article  CAS  Google Scholar 

  3. Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM (2005) GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43(6):1007–1012

    Article  CAS  Google Scholar 

  4. Hu B, Tian X, Sun J, Meng X (2012) Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Int J Mol Sci 14(12):23559–23580

    Article  Google Scholar 

  5. Tian L, Wang Y, Xu D, Gui J, Jia X, Tong H, Wen X, Dong Z, Tian Y (2011) Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases. Int J Cancer 129(8):1923–1931

    Article  CAS  Google Scholar 

  6. Iftikhar R, Kladney RD, Havlioglu N, Schmittgräff A, Gusmirovic I, Solomon H, Luxon BA, Bacon BR, Fimmel CJ (2004) Disease- and Cell-specific expression of GP73 in human liver disease. Am J Gastroenterol 99(6):1087–1095

    Article  CAS  Google Scholar 

  7. Maitra A, Thuluvath PJ (2004) GP73 and liver disease: a (Golgi) complex enigma. Am J Gastroenterol 99(6):1096–1098

    Article  Google Scholar 

  8. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ (2002) Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35(6):1431–1440

    Article  CAS  Google Scholar 

  9. Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ (2000) GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249(1–2):53–65

    Article  CAS  Google Scholar 

  10. Drake RR, Schwegler EE, Malik G, Diaz J, Block T, Mehta A, Semmes OJ (2006) Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics 5(10):1957–1967

    Article  CAS  Google Scholar 

  11. Norton PA, Comunale MA, Krakover J, Rodemich L, Pirog N, D'Amelio A, Philip R, Mehta AS, Block TM (2008) N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem 104(1):136–149

    Article  CAS  Google Scholar 

  12. Jiang K, Shang S, Li W, Guo K, Qin X, Zhang S, Liu Y (2015) Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases. Glycoconj J 32(9):657–664. doi:10.1007/s10719-015-9614-6

    Article  Google Scholar 

  13. Hao L, Yue H, Yue Y, Weiwei L, Yongmei Y, Genxi L (2015) Peptide-based method for detection of metastatic transformation in primary tumors of breast cancer. Anal Chem 87(18):9251–9256

    Article  Google Scholar 

  14. Liu F, Gao T, Ye Z, Yang D, Wang Z, Li G (2014) An electrochemical method to assay human 8-oxoguanine DNA glycosylase 1. Electrochem Commun 50:51–54

    Article  Google Scholar 

  15. Zhu X, Zhang B, Ye Z, Shi H, Shen Y, Li G (2015) An ATP-responsive smart gate fabricated with a graphene oxide-aptamer-nanochannel architecture. Chem Commun 51(4):640–643

    Article  CAS  Google Scholar 

  16. Chen H, Mei Q, Hou Y, Zhu X, Koh K, Li X, Li G (2013) Fabrication of a protease sensor for caspase-3 activity detection based on surface plasmon resonance. Analyst 138(19):5757–5761

    Article  CAS  Google Scholar 

  17. Zhu X, Shen Y, Cao J, Yin L, Ban F, Shu Y, Li G (2015) Detection of microRNA SNPs with ultrahigh specificity by using reduced graphene oxide-assisted rolling circle amplification. Chem Commun 51(49):10002–10005

    Article  CAS  Google Scholar 

  18. Du J, Hong J, Xu C, Cai Y, Xiang B, Zhou C, Xu X (2015) Screening and identification of ssDNA aptamer for human GP73. Biomed Res Int 2015:610281–610281. doi:10.1155/2015/610281

    Google Scholar 

  19. Zhang J, Lv J, Wang X, Li D, Wang Z, Li G (2015) Integration of chemoselective ligation with enzymespecific catalysis: Saccharic colorimetric analysis using aminooxy/hydrazine-functionalized gold nanoparticles. Nano Res 8(12):3853–3863. doi:10.1007/s12274-015-0885-9

    Article  CAS  Google Scholar 

  20. Yang Y, Li C, Yin L, Liu M, Wang Z, Shu Y, Li G (2014) Enhanced charge transfer by gold nanoparticle at DNA modified electrode and its application to label-free DNA detection. ACS Appl Mater Interfaces 6(10):7579–7584. doi:10.1021/am500912m

    Article  CAS  Google Scholar 

  21. Gao T, Liu F, Yang D, Yu Y, Wang Z, Li G (2015) Assembly of selective biomimetic surface on an electrode surface: a Design of Nano-bio Interface for Biosensing. Anal Chem 87(11):5683–5689. doi:10.1021/acs.analchem.5b00816

    Article  CAS  Google Scholar 

  22. Zhang J, Liu Y, Lv J, Li G (2014) A colorimetric method for α-glucosidase activity assay and its inhibitor screening based on aggregation of gold nanoparticles induced by specific recognition between phenylenediboronic acid and 4-aminophenyl-α-d-glucopyranoside. Nano Res 8(3):920–930

    Article  Google Scholar 

  23. Huang Y, Li H, Gao T, Liu X, Li G (2014) A sensitive method for protein assays using a peptide-based nano-label: human glypican-3 detection for hepatocellular carcinomas diagnosis. Analyst 139(15):3744–3747

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work is supported by the National Natural Science Foundation of China (Grant Nos. 81602737, 81672307), and the Science Foundation of Jiangsu Province, China (Grant No. BM2015023).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhaoxia Wang or Yang Xiang.

Ethics declarations

The author(s) declare that they have no competing interests.

Electronic supplementary material

ESM 1

(DOCX 105 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Wang, B., Gu, S. et al. Amperometric low potential aptasensor for the fucosylated Golgi protein 73, a marker for hepatocellular carcinoma. Microchim Acta 184, 3131–3136 (2017). https://doi.org/10.1007/s00604-017-2334-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00604-017-2334-9

Keywords

Navigation